Nguồn ngoài

Pharmacology for Nurses

Pharmacology for Nurses is intended for nursing students in an introductory program. It provides a fundamental understanding of the therapeutic use of drugs, so the nurse can provide safe and effective care to the client. Along with a discussion of each body system, the text also reviews the pathophysiology of various disease processes and medications used in treatment.

Nursing Medicine

Tác giả: Openstax
Nhà xuất bản: LibreTexts
Nguồn: LibreTexts
Giấy phép: CC BY
Ngôn ngữ: EN

Đọc trực tuyến Tải PDF (nguồn mở)

Mục lục· 405 mục

01: Introduction to Pharmacology
1.00: Introduction
1.01: Pharmacology Interdisciplinary Teams and Nursing Practice
1.02: Drug Sources Forms and Names
1.03: Drug Classifications and Prototypes
1.04: Special Considerations
1.05: Chapter Summary
1.06: Key Terms
1.07: Review Questions
02: Drug Administration
2.00: Introduction
2.01: Drug Administration and the Nursing Process
2.02: Pharmacokinetics and Pharmacodynamics
2.03: Drug Administration Routes Preparation and Administration
2.04: Dosage Calculations
2.05: Chapter Summary
2.06: Key Terms
2.07: Review Questions
03: Ethics Legal Considerations and Safety
3.00: Introduction
3.01: Legal Considerations
3.02: Drug Errors and Prevention
3.03: Documentation and Informatics
3.04: Chapter Summary
3.05: Key Terms
3.06: Review Questions
04: Introduction to Homeostasis
4.00: Introduction
4.01: What Is Homeostasis
4.02: Osmolality
4.03: Maintaining Homeostasis
4.04: Negative Feedback Loop
4.05: Chapter Summary
4.06: Key Terms
4.07: Review Questions
05: Fluids and Electrolytes Vitamins Minerals and Alternative Therapies
5.00: Introduction
5.01: Fluid Volume
5.02: Electrolytes
5.03: Intravenous Fluid Therapy Total Parenteral Nutrition and Blood Products
5.04: Vitamins Minerals and Complementary and Alternative Therapies
5.05: Chapter Summary
5.06: Key Terms
5.07: Review Questions
06: Introduction to the Immune System and the Inflammatory Response
6.00: Introduction
6.01: Introduction to Immunity
6.02: Vaccine-Preventable Diseases Vaccines and Immunizations
6.03: Immunosuppressants Biologics Monoclonal Antibodies and Biosimilar Drugs
6.04: Introduction to the Inflammatory Response and Anti-inflammatory Drugs
6.05: Chapter Summary
6.06: Key Terms
6.07: Review Questions
07: Anti-Infective Drugs
7.00: Introduction
7.01: Introduction to Bacterial Viral COVID-19 and Fungal Infections
7.02: Antibiotic Antiviral AntiCOVID-19 and Antifungal Drugs
7.03: Introduction to HIV AIDS and Antiretrovirals
7.04: Introduction to Sexually Transmitted Infections and Drugs to Treat Them
7.05: Introduction to Tuberculosis and Antitubercular Drugs
7.06: Antiparasitic and Anthelminthic Drugs
7.07: Chapter Summary
7.08: Key Terms
7.09: Review Questions
08: Introduction to Cancer Therapy and Cancer Drugs
8.00: Introduction
8.01: Introduction to Cancer and Phases of Cancer Therapy
8.02: Chemotherapeutic Drugs
8.03: Hormonal Therapy
8.04: Biologic Response Modifiers
8.05: Chapter Summary
8.06: Key Terms
8.07: Review Questions
09: Introduction to the Nervous System
9.00: Introduction
9.01: Introduction to the Nervous System
9.02: Structure and Function of the Nervous System
9.03: Characteristics of Drugs to Treat Nervous System Disorders
9.04: Chapter Summary
9.05: Key Terms
9.06: Review Questions
10: Drugs to Treat Myasthenia Gravis and Alzheimers Disease
10.00: Introduction
10.01: Introduction to Myasthenia Gravis
10.02: Cholinergic Drugs
10.03: Introduction to Alzheimer's Disease
10.04: Alzheimers Drugs
10.05: Chapter Summary
10.06: Key Terms
10.07: Review Questions
11: Drugs to Treat Parkinsons Disease and Multiple Sclerosis
11.00: Introduction
11.01: Introduction to Parkinsons Disease
11.02: Anti-Parkinsonian Drugs
11.03: Introduction to Multiple Sclerosis
11.04: Drugs Used in the Treatment of Multiple Sclerosis
11.05: Chapter Summary
11.06: Key Terms
11.07: Review Questions
12: Anticonvulsant Drugs and Drugs to Treat Epilepsy Migraine Headaches and Intracranial Emergencies
12.00: Introduction
12.01: Epilepsy and Anticonvulsant Drugs
12.02: Migraine Headaches and Migraine Headache Drugs
12.03: Intracranial Emergencies and Intracranial Emergency Drugs
12.04: Chapter Summary
12.05: Key Terms
12.06: Review Questions
13: Psychopharmacologic Drugs
13.00: Introduction
13.01: Antidepressants
13.02: Antipsychotics
13.03: Mood Stabilizers
13.04: Anxiolytics and Sedative-Hypnotics
13.05: CNS Stimulants and Nonstimulants
13.06: Chapter Summary
13.07: Key Terms
13.08: Review Questions
14: Pain Response Drugs
14.00: Introduction
14.01: Introduction to Pain
14.02: Nonopioid Analgesics
14.03: Opioid Agonists and Antagonists
14.04: Chapter Summary
14.05: Key Terms
14.06: Review Questions
15: Substance Use Disorder Treatment Drugs
15.00: Introduction
15.01: Introduction to Substance Use Disorders
15.02: Opioid Use Disorder Drugs
15.03: Alcohol Use Disorder Drugs
15.04: Nicotine Use Disorder Drugs
15.05: Chapter Summary
15.06: Key Terms
15.07: Review Questions
16: Introduction to the Cardiovascular System
16.00: Introduction
16.01: Introduction to the Heart Circulation and Blood Flow
16.02: Pumping Action of the Heart
16.03: Conduction of Electrical Impulses
16.04: Chapter Summary
16.05: Key Terms
16.06: Review Questions
17: Antidysrhythmic Drugs
17.00: Introduction
17.01: Introduction to Dysrhythmias
17.02: Class I- Sodium Channel Blockers
17.03: Class II- Beta Adrenergic Blockers
17.04: Class III- Potassium Channel Blockers
17.05: Class IV- Calcium Channel Blockers
17.06: Unclassified Antidysrhythmics
17.07: Chapter Summary
17.08: Key Terms
17.09: Review Questions
18: Antihypertensive and Antianginal Drugs
18.00: Introduction
18.01: Hypertension and Angina
18.02: Angiotensin-Converting Enzyme (ACE) Inhibitors
18.03: Angiotensin II Receptor Blockers (ARBs)
18.04: Beta-Adrenergic Blockers
18.05: Calcium Channel Blockers
18.06: Diuretics
18.07: Nitrates
18.08: Chapter Summary
18.09: Key Terms
18.10: Review Questions
19: Heart Failure Drugs
19.00: Introduction
19.01: Heart Failure
19.02: Drugs Affecting the Renin-Angiotensin-Aldosterone System
19.03: Beta-Adrenergic Blockers
19.04: Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is)
19.05: Diuretics
19.06: Adjunct Medications Used in Heart Failure
19.07: Chapter Summary
19.08: Key Terms
19.09: Review Questions
20: Anticoagulant Antiplatelet and Thrombolytic Drugs
20.00: Introdcution
20.01: Introduction to Clotting and Coagulation
20.02: Anticoagulants
20.03: Antiplatelets
20.04: Thrombolytics
20.05: Chapter Summary
20.06: Key Terms
20.07: Review Questions
21: Lipid-Lowering Drugs
21.00: Introduction
21.01: Introduction to Lipoprotein and Apolipoproteins
21.02: Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
21.03: Bile Acid Sequestrants Fibrates and Niacin
21.04: Cholesterol Absorption Inhibitors
21.05: Chapter Summary
21.06: Key Terms
21.07: Review Questions
22: Cardiac Emergency and Shock Drugs
22.00: Introduction
22.01: Introduction to Cardiac Emergencies and Shock
22.02: Cardiac Emergency Drugs
22.03: Shock Drugs
22.04: Chapter Summary
22.05: Key Terms
22.06: Review Questions
23: Introduction to the Respiratory System
23.00: Introduction
23.01: Introduction to the Upper Respiratory System
23.02: Introduction to the Lower Respiratory System
23.03: Oxygenation and Gas Exchange
23.04: Chapter Summary
23.05: Key Terms
23.06: Review Questions
24: Upper Respiratory Disorder Drugs
24.00: Introduction
24.01: Antihistamines and Decongestants
24.02: Antitussives
24.03: Expectorants and Mucolytics
24.04: Chapter Summary
24.05: Key Terms
24.06: Review Questions
25: Lower Respiratory Disorder Drugs
25.00: Introduction
25.01: Adrenergics and Anticholinergics
25.02: Corticosteroids
25.03: Xanthines Leukotriene Modifiers and Mast Cell Stabilizers
25.04: Chapter Summary
25.05: Key Terms
25.06: Review Questions
26: Hypothalamus Pituitary and Adrenal Disorder Drugs
26.00: Introduction
26.01: Introduction to the Adrenal Cortex Pituitary and Hypothalamus
26.02: Growth Hormones and Suppressants
26.03: Antidiuretic Hormones
26.04: Glucocorticoids and Mineralocorticoids
26.05: Chapter Summary
26.06: Key Terms
26.07: Review Questions
27: Thyroid and Parathyroid Disorder Drugs
27.00: Introduction
27.01: Introduction to the Thyroid and Parathyroid
27.02: Thyroid and Antithyroid Drugs
27.03: Calcium Preparations Vitamin D Bisphosphonates Calcimimetics and Peptide Hormones
27.04: Chapter Summary
27.05: Key Terms
27.06: Review Questions
28: Diabetic Drugs
28.00: Introduction
28.01: Introduction to Diabetes
28.02: Insulin and Non-Insulin Injectable Diabetes Drugs
28.03: Oral Antidiabetic Drugs
28.04: Chapter Summary
28.05: Key Terms
28.06: Review Questions
29: Introduction to the Digestive System
29.00: Introduction
29.01: Introduction to the Gastrointestinal System and Oral Cavity
29.02: Introduction to the Esophagus and Stomach
29.03: Introduction to the Small and Large Intestines
29.04: Chapter Summary
29.05: Key Terms
29.06: Review Questions
30: Gastrointestinal Disorder Drugs
30.00: Introduction
30.01: Antiemetics
30.02: Antidiarrheals
30.03: Laxatives and Stool Softeners
30.04: Chapter Summary
30.05: Key Terms
30.06: Review Questions
31: Hyperacidity and Antiulcer Drugs
31.00: Introduction
31.01: Antacids
31.02: Histamine Blockers and Proton-Pump Inhibitors
31.03: Pepsin Inhibitors and Prostaglandin Analogues
31.04: Chapter Summary
31.05: Key Terms
31.06: Review Questions
32: Weight Management Drugs
32.00: Introduction
32.01: Introduction to Weight Management
32.02: Anorexiants
32.03: Lipase Inhibitors
32.04: Other Drugs Supplements and Herbal Remedies
32.05: Chapter Summary
32.06: Key Terms
32.07: Review Questions
33: Introduction to the Renal and Urinary Systems
33.00: Introduction
33.01: Introduction to the Renal System
33.02: Renal-Associated Fluid Volume Excess
33.03: Introduction to the Urinary System
33.04: Chapter Summary
33.05: Key Terms
33.06: Review Questions
34: Diuretic Drugs
34.00: Introduction
34.01: Introduction to Diuretics
34.02: Loop Diuretics
34.03: Osmotic Diuretics
34.04: Potassium-Sparing Diuretics
34.05: Thiazide and Thiazide-Like Diuretics
34.06: Chapter Summary
34.07: Key Terms
34.08: Review Questions
35: Urinary and Bladder Disorder Drugs
35.00: Introduction
35.01: Urinary Anti-infectives
35.02: Urinary Antispasmodics Antimuscarinics and Anticholinergics
35.03: Urinary Analgesics
35.04: Urinary Stimulants
35.05: Phosphodiesterase 5 Inhibitors
35.06: Chapter Summary
35.07: Key Terms
35.08: Review Questions
36: Reproductive Health Drugs
36.00: Introduction
36.01: Review of the Female Reproductive System
36.02: Hormonal Contraception and Infertility Drugs
36.03: Uterine Motility Drugs and Lactation Considerations
36.04: Bisphosphonates Calcium Preparations Vitamin D and Estrogen Receptor Modulators
36.05: Review of the Male Reproductive System
36.06: Androgens Antiandrogens and Anabolic Steroids
36.07: Phosphodiesterase 5 Inhibitors
36.08: Alpha Blockers and 5-Alpha-Reductase Inhibitors
36.09: Chapter Summary
36.10: Key Terms
36.11: Review Questions
37: Transgender and Nonbinary Drugs
37.00: Introduction
37.01: Overview of Transgender and Nonbinary Health
37.02: Feminizing Hormonal Therapy
37.03: Masculinizing Hormonal Therapy
37.04: Chapter Summary
37.05: Key Terms
37.06: Review Questions
38: Ophthalmic Drugs
38.00: Introduction
38.01: Introduction to the Eyes
38.02: Ocular Anti-inflammatories and Anti-infectives
38.03: Ocular Anesthetics and Lubricants
38.04: Antiglaucoma Drugs
38.05: Chapter Summary
38.06: Key Terms
38.07: Review Questions
39: Otic Drugs
39.00: Introduction
39.01: Introduction to the Ears
39.02: Otic Anti-inflammatories and Anti-infectives
39.03: Otic Antihistamines Decongestants and Cerumenolytics
39.04: Chapter Summary
39.05: Key Terms
39.06: Review Questions
40: Dermatologic Disorder Drugs
40.00: Introduction
40.01: Introduction to the Skin and Its Function
40.02: Acne Drugs
40.03: Psoriatic Drugs
40.04: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
40.05: Chapter Summary
40.06: Key Terms
40.07: Review Questions
41: Appendix
41.00: Appendix A- International System of Units
41.01: Appendix B- Common Abbreviations and Lab Values
41.02: Appendix C- Drug Conversion Tables
41.03: Answer Key
41.3.00: Chapter 1
41.3.01: Chapter 2
41.3.02: Chapter 3
41.3.03: Chapter 4
41.3.04: Chapter 5
41.3.05: Chapter 6
41.3.06: Chapter 7
41.3.07: Chapter 8
41.3.08: Chapter 9
41.3.09: Chapter 10
41.3.10: Chapter 11
41.3.11: Chapter 12
41.3.12: Chapter 13
41.3.13: Chapter 14
41.3.14: Chapter 15
41.3.15: Chapter 16
41.3.16: Chapter 17
41.3.17: Chapter 18
41.3.18: Chapter 19
41.3.19: Chapter 20
41.3.20: Chapter 21
41.3.21: Chapter 22
41.3.22: Chapter 23
41.3.23: Chapter 24
41.3.24: Chapter 25
41.3.25: Chapter 26
41.3.26: Chapter 27
41.3.27: Chapter 28
41.3.28: Chapter 29
41.3.29: Chapter 30
41.3.30: Chapter 31
41.3.31: Chapter 32
41.3.32: Chapter 33
41.3.33: Chapter 34
41.3.34: Chapter 35
41.3.35: Chapter 36
41.3.36: Chapter 37
41.3.37: Chapter 38
41.3.38: Chapter 39
41.3.39: Chapter 40
41.04: References